Back to search

Article

Alternative Strategies to Increase the Immunogenicity of Covid-19 Vaccines in Kidney Transplant Recipients Not Responding to Two or Three Doses of an mRNA Vaccine. A Randomized Clinical Trial

2022-07-29

Abstract excerpt

Background: An urgent need exists to improve the suboptimal COVID-19 vaccine response in kidney transplant recipients (KTR). We compared three alternative strategies with a control single dose mRNA-1273 vaccination: a double vaccine dose, heterologous vaccination and temporary discontinuation of mycophenolate mofetil or mycophenolic acid (MMF/MPA).<br><br>Methods: This prospective, multicentre, open-label randomiz...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8ca566d8-7bd8-5d7c-8101-5a2e52ddd38f
DOI
10.2139/ssrn.4176376
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Alternative Strategies to Increase the Immunogenicity of Covid-19 Vaccines in Kidney Transplant Recipients Not Responding to Two or Three Doses of an mRNA Vaccine. A Randomized Clinical TrialDOI 10.2139/ssrn.4176376
A systematic review assessing the effectiveness of COVID-19 mRNA vaccines in chronic kidney disease (CKD) individualsSemantic proximity
Antibody and T-Cell Responses 6 Months after Covid-19 mRNA-1273 Vaccination in Patients with Chronic Kidney Disease, on Dialysis, or Living with a Kidney TransplantSemantic proximity
Safety and Cross-Variant Immunogenicity of a Three-Dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant RecipientsSemantic proximity
A Third COVID-19 Vaccine Dose in Kidney Transplant Recipients Induces Antibody Response to Vaccine and Omicron Variants but Shows Limited Ig Subclass SwitchingSemantic proximity
Impact of Maintenance Immunosuppression Regimen on Anti-SARS-CoV-2 Antibody Kinetics In Kidney Transplant Recipients Receiving ChAdOx1 as Primary VaccinationSemantic proximity
Diminished antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipientsSemantic proximity
HUMORAL AND CELLULAR IMMUNOGENICITY and SAFETY UP TO 4 MONTHS AFTER VACCINATION WITH BNT162B2 mRNA COVID-19 VACCINE IN HEART AND LUNG TRANSPLANTED YOUNG ADULTSSemantic proximity
SARS-CoV-2 Vaccine Non-response among Hematopoietic Stem Cell Transplant Patients: A Systematic Review and Meta-analysisSemantic proximity
Humoral immune responses against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccineSemantic proximity
Humoral and Cellular Immunogenicity and Safety of 3 Doses of CoronaVac and BNT162b2 in Young Children and Adolescents with Kidney DiseasesSemantic proximity
Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipientsSemantic proximity
Comparative immunogenicity of heterologous versus homologous 3rd SARS-CoV-2 vaccine doses in kidney transplant recipientsSemantic proximity
Select a neighboring publication to make it the new centre.